Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum HEPATOLOGY Cheung, A., Neuschwander-Tetri, B. A., Kleiner, D. E., Schabel, E., Rinella, M., Harrison, S., Ratziu, V., Sanyal, A. J., Loomba, R., Megnien, S., Torstenson, R., Miller, V., Abdelmalek, M., Anstee, Q., Banerjee, R., Bashir, M., Bedossa, P., Berner-Hansen, M., Chakravarthy, M., Charles, E., Dimick-Santos, L., Ertle, J., Francque, S., Friedman, S., Gannedahl, G., Greene, K., Hambleton, M., Hum, D., Imperial, J., Leeming, D., Mehta, R., Naoumov, N., Omokaro, S., Palmer, M., Peres, D., Powell, M., Regev, A., Rosen, G., Sanyal, A., Schoelch, C., Schwimmer, J., Shringarpure, R., Schwander-Tetri, B., Ukomadu, C., Wong, V., Wright, T., Chan, J., Tai, D., Liver Forum Case Definitions Worki 2019; 70 (5): 1841–55

View details for DOI 10.1002/hep.30672

View details for Web of Science ID 000493023400026